Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360133
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-11
First Post:
2024-04-06
Brief Title:
Study of 5 VVN001 Ophthalmic Solution in Dry Eye Disease
Sponsor:
VivaVision Biotech Inc
Organization:
VivaVision Biotech Inc
Study Overview
Official Title:
A Phase 3 Randomized Double-Masked Vehicle-controlled Multi-center Study Evaluating the Safety and Efficacy of 5 VVN001 in Chinese Subjects With Dry Eye Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 3 randomized double-Masked vehicle-controlled multi-center study designed to evaluate the safety and efficacy of 5 VVN001 Ophthalmic Solution versus vehicle in Chinese subjects with dry eye disease
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None